Towards understanding the role of nanomedicine in targeting TNFR2 in rheumatoid arthritis

Rheumatoid arthritis (RA) is a chronic autoimmune disease characterized by inflammation of the synovium and progressive joint destruction which significantly affects both quality of life and socioeconomic status. Admittedly, various treatments are available, but they are usually accompanied by vario...

Full description

Saved in:

Bibliographic Details
Published in:	Immunology Vol. 173; no. 4; pp. 622 - 633
Main Authors:	Lambuk, Fatmawati, Nordin, Nor Asyikin, Mussa, Ali, Lambuk, Lidawani, Ahmad, Suhana, Hassan, Rosline, Kadir, Ramlah, Mohamud, Rohimah, Yahya, Nurul Khaiza
Format:	Journal Article
Language:	English
Published:	England Wiley Subscription Services, Inc 01.12.2024
Subjects:	Animals Antirheumatic Agents - therapeutic use Apoptosis Arthritis Arthritis, Rheumatoid - drug therapy autoimmune disease Autoimmune diseases Control equipment Drug development Health services Humans Inflammation Molecular Targeted Therapy Nanomedicine - methods Nanoparticles Nanoparticles - therapeutic use Nanotechnology Necroptosis Pathophysiology Precision medicine Quality of life Receptors, Tumor Necrosis Factor, Type II - antagonists & inhibitors Receptors, Tumor Necrosis Factor, Type II - metabolism Rheumatoid arthritis Rheumatoid synovitis Side effects Signal Transduction - drug effects Socioeconomics Tumor necrosis factor Tumor necrosis factor receptors Tumor Necrosis Factor-alpha - antagonists & inhibitors Tumor Necrosis Factor-alpha - metabolism Tumor necrosis factor-TNF tumour necrosis factor receptor 2 (TNFR2) tumour necrosis factor‐alpha (TNF‐α) nanoparticles autoimmune disease rheumatoid arthritis tumour necrosis factor receptor 2 (TNFR2) tumour necrosis factor‐alpha (TNF‐α) tumour necrosis factor-alpha (TNF-alpha)
ISSN:	0019-2805, 1365-2567, 1365-2567
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Be the first to leave a comment!